Respiratory Medicine
Volume 101, Issue 1 , Pages 118-129 , January 2007

A comparison of the relative growth velocities with budesonide and fluticasone propionate in children with asthma

  • Alexander C. Ferguson

      Affiliations

    • Division of Allergy, University of British Columbia, B.C.'s Children's Hospital, 4480 Oak Street, Vancouver, BC,Canada V6H 3V4
    • Corresponding Author InformationCorresponding author. Department of Paediatrics, University of British Columbia, BC Children's Hospital, Vancouver, BC, Canada V6H 3V4. Tel.: 16048752118; fax: 16048753653.
  • ,
  • Hugo P. Van Bever

      Affiliations

    • Department of Paediatrics, National University Hospital, 5 Lower Kent Ridge Road, 119074 Singapore, Singapore
  • ,
  • Alejandro M. Teper

      Affiliations

    • Hospital Niños “Ricardo Gutierrez”, Gallo 1330, Buenos Aires, Argentina
  • ,
  • Olga Lasytsya

      Affiliations

    • Kiev Medical Academy of Postgraduate Education, 9 Dorogozshitskaya St., Kiev-112, Ukraine
  • ,
  • Caroline H. Goldfrad

      Affiliations

    • GlaxoSmithKline Research and Development Limited, Greenford Road, Greenford, Middlesex UB6 OHE, UK
  • ,
  • Philip J. Whitehead

      Affiliations

    • GlaxoSmithKline Research and Development Limited, Greenford Road, Greenford, Middlesex UB6 OHE, UK

Received 26 September 2005 ,Accepted 11 April 2006.

References 

  1. Global initiative for asthma. Global strategy for asthma management and prevention (revised 2002). NIH publication No. 02-3659. Bethesda, MD: National Institutes of Health; 2002.
  2. Covar RA, Leung DY, McCormick D, Steelman J, Zeitler P, Spahn JD. Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma. J Allergy Clin Immunol. 2000;106:651–659
  3. Trembath PW. Corticosteroids in asthma: inhaled or oral?. Drugs. 1980;20:81–86
  4. Kamada AK, Szefler SJ. Glucocorticoids and growth in asthmatic children. Pediatr Allergy Immunol. 1995;6:145–154
  5. Allen DB. Growth suppression by glucocorticoid therapy. Endocrinol Metab Clin North Am. 1996;25:699–717
  6. Price J, Hindmarsh P, Hughes S, Efthimiou J. Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature?. Eur Respir J. 2002;19:1179–1193
  7. Ferguson AC, Spier S, Manjra A, Versteegh FG, Mark S, Zhang P. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide. J Pediatr. 1999;134:422–427
  8. de Benedictis FM, Teper A, Green RJ, Boner AL, Williams L, Medley H. Effects of 2 inhaled corticosteroids on growth: results of a randomized controlled trial. Arch Pediatr Adolesc Med. 2001;155:1248–1254
  9. Kannisto S, Korppi M, Remes K, Voutilainen R. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab. 2000;85:652–657
  10. Rao R, Gregson RK, Jones AC, Miles EA, Campbell MJ, Warner JO. Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone. Eur Respir Rev. 1999;12:87–94
  11. Group CAMPR. Long-term effects of budesonide or nedocromil in children with asthma. The childhood asthma management program research group. N Engl J Med. 2000;343:1054–1063
  12. Barnes NC, Hallett C, Harris TA. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir Med. 1998;92:95–104
  13. Price J, Hindmarsh P, Hughes S, Efthimiou J. Evaluating the effects of asthma therapy on childhood growth: principles of study design. Eur Respir J. 2002;19:1167–1178
  14. Polgar G, Promadhat V. Pulmonary function testing in children: techniques and standards. London: WB Saunders; 1971;
  15. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II. Arch Dis Child. 1966;41:613–635
  16. Allen DB, Bronsky EA, LaForce CF, Nathan RA, Tinkelman DG, Vandewalker ML, et al. Growth in asthmatic children treated with fluticasone propionate. Fluticasone propionate asthma study group. J Pediatr. 1998;132:472–477
  17. Adams N, Bestall JM, Jones PW. Fluticasone versus beclomethasone or budesonide for chronic asthma. Cochrane Database Syst Rev. 2002;CD002310
  18. Ferguson AC, Spier S, Manjra A, Versteegh FGA, Mark S, Zhanq P. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide. J. Pediatr. 1999;134(4):422–427
  19. Barnes NC, Hallett C, Harris TAJ. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir. Med. 1998;92(1):95–104
  20. Lipworth BJ, Clark DJ, McFarlane LC. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children. Thorax. 1997;52:686–689
  21. Barnes NC, Marone G, Di Maria GU, Visser S, Utama I, Payne SL. A comparison of fluticasone propionate, 1mg daily, with beclomethasone dipropionate, 2mg daily, in the treatment of severe asthma. International study group. Eur Respir J. 1993;6:877–885
  22. Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma. Arch Dis Child. 1993;69:206–211
  23. Leblanc P, Mink S, Keistinen T, Saarelainen PA, Ringdal N, Payne SL. A comparison of fluticasone propionate 200 micrograms/day with beclomethasone dipropionate 400 micrograms/day in adult asthma. Allergy. 1994;49:380–385
  24. Doull IJ, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with beclomethasone dipropionate. Am J Respir Crit Care Med. 1995;151(6):1715–1719
  25. Malerba M, Bosoni S, Radaeli A, Mori E, Bonadonna S, Guistina A, et al. Growth hormone response to growth-hormone releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment. Chest. 2005;127:515–521
  26. Agertoft and Pedersen. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study. Eur Respir J. 1997;10:1507–1512
  27. Daley-Yates PT, Richards DH. Relationship between systemic exposure to corticosteroids and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model. Clin Ther. 2004;26:1905–1919
  28. Fink RS, Pierre LN, Daley-Yates PT, Richards DH, Gibson A, Honour JW. Hypothalamic–pituitary–adrenal axis function after inhaled corticosteroids: unreliability of urinary free cortisol estimation. J Clin Endocrinol Metab. 2002;87:4541–4546
  29. Skoner DP, Szefler SJ, Welch M, Walton-Bowen K, Cruz-Rivera M, Smith JA. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma. J Allergy Clin Immunol. 2000;105:259–268
  30. Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet. 2003;361:1071–1076
  31. Sharek PJ, Bergman DA. The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis. Pediatrics. 2000;106:E8
  32. Roux C, Kolta S, Desfougeres JL, Minini P, Bidat E. Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma. Pediatrics. 2003;111:e706–e713
  33. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med. 2000;343(15):1064–1069

PII: S0954-6111(06)00220-4

doi: 10.1016/j.rmed.2006.04.009

Respiratory Medicine
Volume 101, Issue 1 , Pages 118-129 , January 2007